insights_auto
Why is AKTX down 8.35%?
Dive Deeperchevron_right
AKTX:NASDAQ
Akari Therapeutics PLC
$7.24
arrow_downward
-8.35%(-0.66) 1D
$7.96
arrow_upward
+9.94% (+0.72)bedtimeAfter hours
Closed: Oct 14, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AKTX...
Open
$8.10
High
$8.10
Low
$7.19
Mkt. cap
16.54M
Avg. vol.
69.48K
Volume
34.89K
52-wk high
$39.64
52-wk low
$3.02
EPS
-$330.40
Beta
1.43
Shares outstanding
1.14M
No. of employees
5
Open
$8.10
High
$8.10
Low
$7.19
Mkt. cap
16.54M
Avg. vol.
69.48K
Volume
34.89K
52-wk high
$39.64
52-wk low
$3.02
EPS
-$330.40
Beta
1.43
Shares outstanding
1.14M
No. of employees
5
News stories
From web sources and news partners
www.marketscreener.com
·
1 day ago
Akari Therapeutics, Plc Announces Appointment of Vatnak Vat-Ho as Chief Business Officer
The Manila Times
·
1 day ago
Akari Therapeutics Appoints Accomplished Oncology and ADC Deal Executive Vatnak Vat-Ho as Chief Business Officer to Drive Strategic Growth and Partnering
StreetInsider
·
1 day ago
Akari Therapeutics names Vatnak Vat-Ho as chief business officer
About Akari Therapeutics PLC
CEO-
Employees5
Founded2004
HeadquartersTampa, Florida, United States
SectorBiotechnology
Websiteakaritx.com